Hypoglycemia is a metabolic condition characterized by a blood glucose level below 70 mg/dL (3.9 mmol/L), in which the brain and peripheral tissues are deprived of their primary energy substrate. It is distinguished from hyperglycemia (abnormally elevated blood glucose) and normoglycemia (normal glucose homeostasis), and must not be confused with hypoglycorrhachia, which refers specifically to low glucose in the cerebrospinal fluid. The underlying mechanism involves an absolute or relative excess of insulin relative to circulating glucose — caused by exogenous insulin or sulfonylurea administration, endogenous overproduction (as in insulinoma), counter-regulatory hormone deficiency, or inadequate carbohydrate intake. Hypoglycemia may be physiological in neonates during the early transitional period (P70.4) or pathological in the setting of diabetes therapy (E11.649, E10.649), fasting, or autonomous insulin secretion. Clinically relevant subtypes include drug-induced hypoglycemia (E16.0), reactive (postprandial) hypoglycemia (E16.1), unspecified hypoglycemia (E16.2), and hypoglycemic coma (E15). Hypoglycemia is commonly confused with hypoglycemic unawareness, which is a specific autonomic failure syndrome in which the adrenergic warning symptoms are absent — a critical coding and clinical distinction.
Noun-forming suffix — “condition of the blood” — indicates presence of a substance in the blood
The word entered English in the 1890s as hypoglycemia (noun), formed directly from New Latin components derived from Greek — literally “condition of low sugar in the blood.” The root glukus (“sweet”) connects hypoglycemia to the entire glyc- root family: glycogen (glyc + -gen → “sugar producer”), glycosuria (glyc + -uria → “sugar in the urine”), and glycolysis (glyc + -lysis → “breakdown of sugar”). The diminishing prefixhypo- is among the most productive in medical terminology, also appearing in hypotension, hypothyroidism, hypoxia, hyponatremia, and hypocalcemia.
Low blood sugar(lay term universally used by patients and caregivers; common in diabetes education settings)
Insulin shock(historical and lay clinical term for severe hypoglycemia with altered consciousness or coma; now largely replaced in clinical documentation)
Reactive hypoglycemia(postprandial form occurring 2-5 hours after eating; coded under E16.1)
Drug-Induced Hypoglycemia(caused by insulin, sulfonylureas, or other antidiabetic agents; coded E16.0; requires an adverse effect code from T36-T50 as an additional code)
Diabetic hypoglycemia(hypoglycemia as a complication of diabetes mellitus; coded with combination codes such as E11.649, E10.649, E13.649 depending on DM type and coma status)
Hypoglycemic coma(severe neurological manifestation with loss of consciousness; coded E15 when not associated with diabetes, or with diabetic combination codes when DM is present)
Neonatal hypoglycemia(transient metabolic hypoglycemia of the newborn, especially in infants of diabetic mothers; coded P70.4)
Insulinoma-related hypoglycemia(autonomous endogenous insulin hypersecretion from a pancreatic beta-cell tumor; see D13.7 for benign insulinoma)
Hypoglycemic unawareness(autonomic neuropathy-related failure to perceive adrenergic warning symptoms; coded under the appropriate diabetic neuropathy combination code)
Fasting hypoglycemia(occurs in the absence of food intake; associated with adrenal insufficiency, hepatic failure, or insulinoma)
Functional hypoglycemia(non-organic, often idiopathic postprandial glucose dysregulation; coded E16.1 or E16.2 depending on documentation)
🔗 RELATED TERMS
Hyperglycemia — the opposite of hypoglycemia; blood glucose is elevated above normal (>180 mg/dL in most clinical definitions); caused by insulin deficiency or resistance rather than insulin excess
normoglycemia — shares the glyc- root; refers to blood glucose within the normal physiological range (70-140 mg/dL fasting/postprandial)
insulin — the primary hormonal driver of hypoglycemia when present in excess, either exogenously administered or endogenously secreted; coded as adverse effect (insulin: T38.3X5A initial, T38.3X5D subsequent)
Glucagon — counter-regulatory hormone released by pancreatic alpha cells to raise blood glucose in response to hypoglycemia; its deficiency or blunted response contributes to hypoglycemic unawareness
Insulinoma — a pancreatic islet-cell tumor that autonomously secretes insulin causing recurrent fasting hypoglycemia; benign form coded D13.7
Diabetic hypoglycemic coma — most severe manifestation of diabetic hypoglycemia; results in loss of consciousness; triggers inpatient admission and requires combination DM + coma codes (e.g., E11.641 for Type 2 DM with hypoglycemia with coma)
Hypoglycemic unawareness — autonomic failure syndrome in long-standing diabetes in which the sympathoadrenal response to falling glucose is blunted; related to diabetic autonomic neuropathy
Glycogen — the storage form of glucose in hepatocytes and muscle; hepatic glycogen depletion is a key mechanism of fasting and alcohol-induced hypoglycemia
Glycolysis — the metabolic pathway by which glucose is broken down for energy; excessive peripheral uptake without adequate hepatic output produces hypoglycemia
Adrenal insufficiency — endocrine condition (coded E27.40 unspecified, E27.1 primary) that causes hypoglycemia due to cortisol deficiency impairing gluconeogenesis
Dumping syndrome — post-gastric surgery complication that can cause reactive/postprandial hypoglycemia; coded K91.1
Continuous glucose monitor (CGM) — primary ambulatory diagnostic and monitoring tool for detecting and trending hypoglycemic episodes; associated with CPT 95250, 95251
Office/outpatient visit, established patient, moderate MDM (common for DM management visit with hypoglycemic episode)
96372
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular (e.g., glucagon injection)
⚠️ Coding Note: For diabetic hypoglycemia, always use the appropriate combination code from the E08-E13 range that captures both the DM type and the hypoglycemia — never code E16.x separately when diabetes is the documented cause, as this constitutes undercoding and may trigger a payer audit. The coma vs. no coma distinction (e.g., E11.641 vs. E11.649) requires explicit physician documentation; query the provider if “altered mental status,” “unresponsive,” or “LOC” appears in the note without a clear coma designation. For drug-induced non-diabetic hypoglycemia (E16.0), always assign an additional adverse effect code from the T38.3X5- range to identify the offending agent — this is a required sequencing step under ICD-10-CM Official Guidelines. A commonly missed inpatient profee opportunity is the E15 code (nondiabetic hypoglycemic coma), which is underused when providers document “hypoglycemic episode with unresponsiveness” in a non-diabetic patient — the documentation trigger phrase to watch for is “insulin shock” or “hypoglycemic stupor.” When neonatal hypoglycemia (P70.4) is the reason for NICU admission, it drives a higher-weighted MS-DRG and must be captured as the principal diagnosis — do not allow it to default to an unspecified newborn code.
Crystal's Coder Hub